Commonly known as atopic dermatitis, eczema is "the itch that rashes," says Dr. Shi, meaning that an itching sensation often occurs first followed by a visible rash that develops after scratching.

Hot off its first approval this summer in psoriasis, Arcutis Biotherapeutics’ roflumilast foam 0.3%, approved in cream form under the brand name Zoryve, is out to prove it’s no one-trick pony in itch.

When a person presents with features of both psoriasis and seborrheic dermatitis (SD), a healthcare professional may diagnose sebopsoriasis. This is a chronic skin condition that has symptoms that ...

Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being treated with topical steroids are concerned about side effectsNearly 8 in 10 ...

Arcutis Biotherapeutics will present two significant posters at the 2025 American Academy of Dermatology annual meeting, showcasing data that reinforces the efficacy and safety of ZORYVE treatments in ...